What are the treatments for lung cancer? Introduction to the two major clinical treatments for lung cancer

Lung cancer threatens the health of patients. As more and more people suffer from lung cancer, lung cancer is people's number one enemy. Patients with lung cancer should not lose confidence in treatment. They should know that maintaining an optimistic attitude towards treatment can also play a certain role in controlling the disease. So what treatment options are available for patients with lung cancer? This is the voice of many patients. Let's introduce it in detail below.

1. Choice of treatment plan for lung cancer There is no consensus on whether chemotherapy is appropriate after surgery for stage I, II, IIIa, IIIb, and IV non-small cell lung cancer. However, adenocarcinoma tends to use chemotherapy. Chemotherapy is recommended after surgery, and postoperative radiotherapy can be considered if conditions permit.

①Strive for radiotherapy or surgery after chemotherapy

②Radiotherapy, strive for surgery + chemotherapy.

③ Meet the indications for extended surgery/or radiotherapy, surgery + radiotherapy + chemotherapy.

Chemotherapy and radiotherapy are the main treatments. Selective chemotherapy and general medical treatment. Small cell lung cancer. Surgery + chemotherapy. Chemotherapy + surgery + chemotherapy. Chemotherapy and radiotherapy are the main treatments. For patients with significant efficacy, surgery and postoperative chemotherapy can be added. Chemotherapy and radiotherapy are the main treatments. Selective chemotherapy and general medical treatment

2. Surgical treatment

In the treatment of lung cancer, except for stage IIIb and IV, surgery should be the main treatment or strive for surgery. According to different stages and pathological tissue types, radiotherapy, chemotherapy and immunotherapy should be added as a comprehensive treatment. The indications and treatment plans for small cell lung cancer need to be continuously revised and improved in clinical practice.

Regarding the survival period after lung cancer surgery, domestic reports have shown that the three-year survival rate is 40% to 60%; the five-year survival rate is 22.9% to 44.3%, and the surgical mortality rate is below 3%.